Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781001 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy
A Phase 1 study, sponsored by Center for Medicinal Cannabis Research.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00781001 is a Phase 1 study that has completed, run by Center for Medicinal Cannabis Research. The registered enrollment target is 17 participants.
The verdict
NCT00781001, a Phase 1 study, has completed, sponsored by Center for Medicinal Cannabis Research.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if vaporized cannabis is effective as an analgesic for the treatment of painful diabetic neuropathy.
Interventions
- DRUG Cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00781001
The ClinicalTrials.gov registry entry for NCT00781001 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Medicinal Cannabis Research, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabis is the first listed.
NCT00781001 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00781001 about?
NCT00781001 is a clinical study titled "Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy". The purpose of this study is to determine if vaporized cannabis is effective as an analgesic for the treatment of painful diabetic neuropathy.
What is the current status of trial NCT00781001?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2008-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00781001?
The interventions under investigation include: Cannabis (DRUG).
Who is sponsoring clinical trial NCT00781001?
This trial is sponsored by Center for Medicinal Cannabis Research, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.